|Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.|
|PMID: 18670224 Owner: NLM Status: MEDLINE|
|OBJECTIVE: To assess hematologic and hepatic toxicities associated with in utero and breastfeeding exposure to maternal highly active antiretroviral therapy (HAART) among infants in Botswana.
DESIGN: A nested cohort study within a randomized clinical trial (the Mashi Study). Laboratory toxicities among infants born to women who initiated HAART before delivery were compared with toxicities among those born to women who received zidovudine and a single dose of nevirapine or placebo in labor. Infants were randomized to breastfeed with extended zidovudine or to formula-feed.
METHODS: Hemoglobin concentrations, absolute neutrophil and platelet counts, and alanine aminotransferase and aspartate aminotransferase levels were recorded from birth to 7 months of age in infants. Grade 3 and 4 toxicities were compared by infant antiretroviral exposure status.
RESULTS: In-utero exposure to maternal HAART was associated with increased risk for neutropenia in infants up to 1 month of age; 21.7% of HAART-exposed infants were neutropenic, compared with 5.5% of the infants exposed to zidovudine (P < 0.01). However, neutropenia was no longer associated with antenatal exposure to HAART after 1 month of age. Postnatal exposure to HAART was not associated with hematologic or hepatic toxicities. Laboratory toxicities were clinically asymptomatic in all but one infant.
CONCLUSION: Exposure to maternal HAART in utero may increase the risk for infant neutropenia, particularly among breastfed infants, but the clinical significance of this finding is uncertain. The lack of association between exposure to HAART through breastfeeding and long-term toxicities in infants is reassuring but deserves study in larger cohorts.
|Woong Hwan Bae; Carolyn Wester; Laura M Smeaton; Roger L Shapiro; Shahin Lockman; Kenneth Onyait; Ibou Thior; Max Essex|
Related Documents :
|20368314 - The burden of suboptimal breastfeeding in the united states: a pediatric cost analysis.
8705984 - Candida: the hidden deterrent to breastfeeding.
19941654 - Exclusive breastfeeding in sri lanka: problems of interpretation of reported rates.
12744534 - Duration of breastfeeding in swedish primiparous and multiparous women.
2108244 - Ascogregarina saraviae n. sp. (apicomplexa: lecudinidae) in lutzomyia lichyi (diptera: ...
7625544 - Hyperekplexia, a cause of neonatal apnea: a case report.
|Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural|
|Title: AIDS (London, England) Volume: 22 ISSN: 1473-5571 ISO Abbreviation: AIDS Publication Date: 2008 Aug|
|Created Date: 2008-08-01 Completed Date: 2008-09-24 Revised Date: 2014-09-17|
Medline Journal Info:
|Nlm Unique ID: 8710219 Medline TA: AIDS Country: England|
|Languages: eng Pagination: 1633-40 Citation Subset: IM; X|
|APA/MLA Format Download EndNote Download BibTex|
Anti-HIV Agents / adverse effects*, therapeutic use
Anti-Retroviral Agents / adverse effects*, therapeutic use
Antiretroviral Therapy, Highly Active / adverse effects
Aspartate Aminotransferases / blood
Biological Markers / blood
HIV Infections / drug therapy*, immunology, transmission*
Hemoglobins / analysis
Infectious Disease Transmission, Vertical
Neutropenia / etiology, immunology
Nevirapine / adverse effects, therapeutic use
Pregnancy Complications, Infectious / drug therapy*, immunology
Prenatal Exposure Delayed Effects
Zidovudine / adverse effects, therapeutic use
|K23 HD049292/HD/NICHD NIH HHS; K23 HD049292-03/HD/NICHD NIH HHS; R01 HD037793/HD/NICHD NIH HHS; R01 HD037793-05/HD/NICHD NIH HHS; R01 HD37793/HD/NICHD NIH HHS|
|0/Anti-HIV Agents; 0/Anti-Retroviral Agents; 0/Biological Markers; 0/Hemoglobins; 4B9XT59T7S/Zidovudine; 99DK7FVK1H/Nevirapine; EC 126.96.36.199/Aspartate Aminotransferases; EC 188.8.131.52/Alanine Transaminase|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
Next Document: HIV prevalence and incidence are no longer falling in southwest Uganda: evidence from a rural popula...